Michael Yee
Stock Analyst at Jefferies
(1.24)
# 1652
Out of 5,240 analysts
93
Total ratings
36.17%
Success rate
12.07%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
ALX Oncology Holding... | Downgrades: Hold | 12 2 | 1.61 | 24.22% | 4 | Dec 19, 2024 | |
Kodiak Sciences | Upgrades: Buy | 20 | 8 | 150% | 3 | Dec 9, 2024 | |
Biogen | Downgrades: Hold | 250 180 | 145.32 | 23.86% | 5 | Dec 9, 2024 | |
Vertex Pharmaceutica... | Upgrades: Buy | 500 550 | 419.49 | 31.11% | 4 | Dec 9, 2024 | |
Amgen | Maintains: Buy | 380 380 | 270.74 | 40.36% | 5 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 40 45 | 20.23 | 122.44% | 2 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 65 55 | 34.71 | 58.46% | 8 | Oct 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 35 | 12.74 | 174.73% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 40 | n/a | n/a | 1 | Sep 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 385 | 593.45 | -35.13% | 4 | Jul 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 2 10 | 2.71 | 269% | 3 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 28 32 | 11.83 | 170.5% | 2 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 16 3 | 1.94 | 54.64% | 2 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 7 4 | n/a | n/a | 2 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 40 45 | n/a | n/a | 1 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 75 30 | 24.49 | 22.5% | 2 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 3 1 | 0.53 | 88.68% | 5 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 8 20 | 44.48 | -55.04% | 3 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 35 | n/a | n/a | 1 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 160 200 | n/a | n/a | 1 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 63 75 | 31.98 | 134.52% | 1 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 46 10 | n/a | n/a | 2 | Dec 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 30 | 1.97 | 1422.84% | 1 | Nov 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 65 | 28.6 | 127.27% | 1 | Mar 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 75 45 | 0.55 | 8081.82% | 2 | Mar 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 40 30 | 2.21 | 1257.47% | 4 | Feb 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 15 30 | 13.02 | 130.41% | 3 | Feb 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 30 | n/a | n/a | 2 | Dec 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 120 | 14.93 | 703.75% | 2 | Nov 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 70 75 | 19.82 | 278.41% | 2 | Oct 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 30 | 12.76 | 135.11% | 1 | Sep 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Buy | 30 | n/a | n/a | 2 | Nov 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Buy | 77 | 10.48 | 634.73% | 2 | Nov 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 93 0 | n/a | n/a | 3 | Jan 26, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 40 | n/a | n/a | 1 | Jan 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 2640 3000 | n/a | n/a | 2 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 13 18 | n/a | n/a | 3 | Oct 9, 2017 |